Stephen Baxter
Stock Analyst at Wells Fargo
(3.56)
# 2,219
Out of 5,070 analysts
716
Total ratings
48.5%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Stephen Baxter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CI The Cigna Group | Maintained: Hold | $307 | $271.83 | +12.94% | 42 | Oct 1, 2026 | |
| OSCR Oscar Health | Rated: Hold | $27 | $30.84 | -12.45% | 33 | Sep 16, 2026 | |
| CNC Centene | Reiterated: Hold | $69 | $62.12 | +11.08% | 52 | Sep 15, 2026 | |
| CVS CVS Health | Reiterated: Buy | $123 | $85.69 | +43.54% | 53 | Sep 15, 2026 | |
| ELV Elevance Health | Reiterated: Buy | $473 | $388.82 | +21.65% | 50 | Sep 15, 2026 | |
| HUM Humana | Reiterated: Buy | $502 | $381.57 | +31.56% | 62 | Sep 15, 2026 | |
| MOH Molina Healthcare | Reiterated: Hold | $220 | $189.10 | +16.34% | 56 | Sep 15, 2026 | |
| UNH UnitedHealth Group | Reiterated: Buy | $526 | $367.08 | +43.29% | 53 | Sep 15, 2026 | |
| CAH Cardinal Health | Reiterated: Buy | $277 | $222.50 | +24.49% | 23 | Sep 9, 2026 | |
| UHS Universal Health Services | Reiterated: Hold | $166 | $174.26 | -4.74% | 36 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $10.25 | +85.37% | 4 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $28 → $40 | $34.42 | +16.21% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $331 → $395 | $300.25 | +31.56% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $812 → $933 | $853.81 | +9.27% | 26 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 → $34 | $34.70 | -2.02% | 5 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $141 → $146 | $79.59 | +83.44% | 26 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $46 | $38.97 | +18.04% | 12 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $78 | $56.75 | +37.44% | 23 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $369 → $381 | $426.74 | -10.72% | 33 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $231 → $281 | $255.56 | +9.95% | 33 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Sell | $2 | $2.86 | -30.07% | 28 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 | $5.80 | +37.93% | 17 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $40 | $13.58 | n/a | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $235 | $308.11 | n/a | 6 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $88 → $91 | $624.18 | n/a | 2 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $116 | $233.07 | n/a | 1 | Apr 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $203 | $295.01 | n/a | 1 | Feb 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $268.85 | n/a | 1 | Nov 14, 2019 |
The Cigna Group
Oct 1, 2026
Maintained: Hold
Price Target: $307
Current: $271.83
Upside: +12.94%
Oscar Health
Sep 16, 2026
Rated: Hold
Price Target: $27
Current: $30.84
Upside: -12.45%
Centene
Sep 15, 2026
Reiterated: Hold
Price Target: $69
Current: $62.12
Upside: +11.08%
CVS Health
Sep 15, 2026
Reiterated: Buy
Price Target: $123
Current: $85.69
Upside: +43.54%
Elevance Health
Sep 15, 2026
Reiterated: Buy
Price Target: $473
Current: $388.82
Upside: +21.65%
Humana
Sep 15, 2026
Reiterated: Buy
Price Target: $502
Current: $381.57
Upside: +31.56%
Molina Healthcare
Sep 15, 2026
Reiterated: Hold
Price Target: $220
Current: $189.10
Upside: +16.34%
UnitedHealth Group
Sep 15, 2026
Reiterated: Buy
Price Target: $526
Current: $367.08
Upside: +43.29%
Cardinal Health
Sep 9, 2026
Reiterated: Buy
Price Target: $277
Current: $222.50
Upside: +24.49%
Universal Health Services
Sep 8, 2026
Reiterated: Hold
Price Target: $166
Current: $174.26
Upside: -4.74%
Aug 14, 2026
Reiterated: Buy
Price Target: $19
Current: $10.25
Upside: +85.37%
Aug 11, 2026
Rated: Buy
Price Target: $28 → $40
Current: $34.42
Upside: +16.21%
Aug 11, 2026
Rated: Buy
Price Target: $331 → $395
Current: $300.25
Upside: +31.56%
Aug 11, 2026
Rated: Hold
Price Target: $812 → $933
Current: $853.81
Upside: +9.27%
Aug 11, 2026
Rated: Hold
Price Target: $47 → $34
Current: $34.70
Upside: -2.02%
Aug 10, 2026
Reiterated: Buy
Price Target: $141 → $146
Current: $79.59
Upside: +83.44%
Aug 10, 2026
Rated: Buy
Price Target: $45 → $46
Current: $38.97
Upside: +18.04%
Aug 3, 2026
Reiterated: Buy
Price Target: $78
Current: $56.75
Upside: +37.44%
Aug 3, 2026
Rated: Hold
Price Target: $369 → $381
Current: $426.74
Upside: -10.72%
Jul 31, 2026
Rated: Buy
Price Target: $231 → $281
Current: $255.56
Upside: +9.95%
Apr 27, 2026
Rated: Sell
Price Target: $2
Current: $2.86
Upside: -30.07%
Oct 29, 2025
Reiterated: Hold
Price Target: $8
Current: $5.80
Upside: +37.93%
May 1, 2024
Reiterated: Hold
Price Target: $4 → $40
Current: $13.58
Upside: n/a
Jan 11, 2021
Downgraded: Hold
Price Target: $235
Current: $308.11
Upside: n/a
May 13, 2020
Downgraded: Hold
Price Target: $88 → $91
Current: $624.18
Upside: n/a
Apr 27, 2020
Upgraded: Hold
Price Target: $116
Current: $233.07
Upside: n/a
Feb 18, 2020
Upgraded: Buy
Price Target: $203
Current: $295.01
Upside: n/a
Nov 14, 2019
Upgraded: Buy
Price Target: n/a
Current: $268.85
Upside: n/a